Medlab Clinical achieved record income during October 2019

  • Nov 11, 2019 AEDT
  • Team Kalkine

Medical research and development company, Medlab Clinical (ASX: MDC) has achieved a record month in cannabis revenue with 846 bottles dispensed in October 2019.

The company witnessed unprecedented increase in demand for NanaBis™, with 735 bottles of NanaBis™ dispensed in October, up 43% over the previous best month.

Two emerging factors differentiating Medlab products include:

  1. NanaBis status with clinical trials at Royal North Shore Hospital
  2. More recently allowing doctors and patients to participate via the TGA (Therapeutic Goods Administration) approved Observational Study designed in collaboration with US FDA (Food and Drug Administration).


All pictures are copyright to their respective owner(s) does not claim ownership of any of the pictures displayed on this website unless stated otherwise. Some of the images used on this website are taken from the web and are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it below the image.


There is no investor left unperturbed with the ongoing trade conflicts between US-China and the devastating bushfire in Australia.

Are you wondering if the year 2020 might not have taken the right start? Dividend stocks could be the answer to that question.

As interest rates in Australia are already at record low levels, find out which dividend stocks are viewed as the most attractive investment opportunity in the current scenario in our report.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK